Azmi Nabulsi - May 31, 2024 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role
Chief Operating Officer
Signature
/s/ Molly Henderson, Attorney-in-Fact for Azmi Nabulsi
Stock symbol
PHAT
Transactions as of
May 31, 2024
Transactions value $
$0
Form type
4
Date filed
5/31/2024, 06:34 PM
Previous filing
Jan 22, 2024
Next filing
Jul 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHAT Common Stoock Award $0 +7.5K +3.1% $0.00 250K May 31, 2024 Direct F1
holding PHAT Common Stock 3.58K May 31, 2024 By 401(k)
holding PHAT Common Stock 786K May 31, 2024 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") granted on May 31, 2024. One third (1/3) of the total number of RSUs granted vest on each of the first three anniversaries of December 18, 2023, the vesting commencement date, subject to the Reporting Person's continued service on the applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.